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HL-R5 AND HL-D4:  TWO DIFFERENTIAT ION RES ISTANT HL-60  
VARIANTS 
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(Received 28 September 1988. Accepted 17 December 1988) 
Abstraet--A wide range of different agents are capable of inducing the onset of HL-60 differentiation 
along the myeloid lineage. The diversity of these agents has made the analysis of the molecular 
mechanisms involved in the regulation of the onset and progress of terminal differentiation i  these 
cells difficult. We have adapted the standard soft-agar cloning procedure to enable the single-step 
selection of clonal populations of spontaneously arising differentiation resistant HL-60 variants. This 
simple procedure which obviates the need for mutagenesis, long-term exposure to inducing agents or 
complex manipulations, optimises the chance of obtaining variants with a single lesion blocking the 
onset of differentiation. The analysis of two variants, HL-R5 and HL-D4, selected by this procedure 
for resistance to retinoic acid and DMSO, respectively, suggests the existence of different pathways 
used by the two agents which converge before the onset of terminal differentiation. 
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INTRODUCTION 
LITTLE IS known about the cellular and molecular 
events regulating the onset and progress of terminal 
differentiation i  myeloid cells. The "promyelocytic" 
cell line HL-60 [1, 2] provides a useful in-vitro model 
for the study of myeloid and monocytic 
differentiation. This cell resembles in many ways an 
immature myeloid cell arrested in a cycle of self- 
renewal, with a limited rate of spontaneous dif- 
ferentiation i culture (approximately 10%). Agents 
such as DMSO [3] and retinoic acid [4] greatly 
enhance this background rate of differentiation 
resulting in the appearance of a vastly increased 
number of cells (more than 80%) that display a 
predominantly myeloid/granulocytic phenotype 
[3, 4]. By contrast, other agents including phorbol 
esters [5] and 1,25(OH)E vitamin D 3 [6] dramatically 
stimulate the appearance of monocyte/macrophage- 
like characteristics in these cells. In addition to the 
above agents it has been demonstrated that the care- 
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ful manipulation of the pH in culture causes the 
appearance ofeosinophile-like c lls in the population 
[7]. Early passage HL-60 cells can also be induced to 
differentiate by naturally occurring factors (DIFs) 
in T-lymphocyte conditioned medium [8], purified 
colony stimulating factors (G-CSF & GM-CSF) 
[9, 10] gamma interferon [11, 12] and tumour necro- 
sis factor [13] (see Ref. [14] for a recent review). The 
existence of such a vast array of diverse compounds 
all of which induce the onset of terminal dif- 
ferentiation i  HL-60 cells has made the analysis of 
the processes involved very difficult. The isolation of 
suitable differentiation resistant subclones, each with 
a discrete lesion in the differentiation pathways used 
by the above agents, would provide a powerful tool 
for the analysis of the control of HL-60 
differentiation. 
Here we report he adaptation of the standard soft- 
agar cloning technique to enable the selection of 
differentiation resistant variants without he need for 
complex manipulations or mutagenesis. The pro- 
cedure is based on the fact that the induction of 
differentiation i HL-60 cells results in the cessation 
of growth, whilst the spontaneously appearing dif- 
ferentiation resist:mr cells continue to proliferate and 
form discrete colonies in soft-agar. This technique 
has allowed the selection of a number of variants 
resistant to the induction of terminal differentiation. 
Here we report he characterisation f two interesting 
variants, HL-D4 and HL-R5. 
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MATERIALS  AND METHODS 
Cell culture 
HL-60 cells in passage 28 were obtained via Dr Ming- 
chi Wu, Biochemistry Department, North Texas State 
University, U.S.A. Cells were maintained below 1 x 106/ 
ml in RPMI medium supplemented with 10% foetal bovine 
serum (FBS), glutamine 2mM, pyruvate 1mM, penicillin 
200 U/ml and streptomycin 200 ~tg/ml. Cultures were incu- 
bated at 37°C in tissue culture flasks, initially equilibrated 
in an atmosphere of 95% air/5% COE. Routinely cells 
were used in passages 30-50. 
For the induction of differentiation, ceils in logarithmic 
growth (doubling time approximately 35h) were adjusted 
to 4 x 105/ml in 10% FBS and an equal volume of medium 
containing DMSO or retinoic acid was added to the desired 
final concentration. Differentiation was then monitored by 
the daily assessment ofcell number, nitroblue tetrazolium 
(NBT) reducing activity and morphological ppearance. 
Cell counts 
Each point represents he mean and standard error of a 
single count (over 100 cells) from three independent cul- 
tures initiated under identical conditions. All counts rep- 
resent viable cell number as assessed by trypan blue 
exclusion using a haemocytometer. 
NBT reduction test 
This test was performed essentially as described by Fer- 
rero et al. [15]. Briefly 1 x 105 cells were washed in Ca/Mg 
free PBS, resuspended in 100 ~tl of 1 mg/ml NBT in 
Ca/Mg free PBS containing 1 ~tg/ml 12-O-tetra- 
decanoylphorbol 13-acetate (TPA). After 30-min 
incubation at 37°C samples were placed on ice and more 
than 100 cells were examined using a haemocytometer. 
Results are expressed as the percentage ofcells with intra- 
cellular blue/black formazan deposits. Each point is the 
average of a single determination on three independent 
cultures initiated under identical conditions. 
Assessment of morphology 
At the indicated times 1 x 105 viable cells were washed 
in Ca/Mg free PBS and spun onto microscope slides using 
a Shandon cytospin at 1000 rev/min for 5 min. Slides were 
air dried, fixed in 100% methanol for 10 min, stained in 
50% v/v May/Griinwald for 10 rain and then in 10% v/v 
Giemsa for 30 min. Stained slides were washed in PBS for 
5 min, rinsed in tap water, counter stained for 20 min in 
Mayers Haemalum, rinsed in tap water, air dried and 
finally mounted in Depex. May/Griinwald and Giemsa 
were diluted freshly each time in Ca/Mg free PBS. 
Isolation of differentiation resistant variants 
HL-60 cells (passage 30-40) in logarithmic growth were 
adjusted to 2 × 105/ml in 25-50% conditioned medium and 
20% FBS in the presence of either 1.25% DMSO or 1 ~tM 
retinoic acid and 0.3% noble agar. This cell suspension 
was added to tissue culture dishes at 20 ml per dish and the 
agar allowed to set at room temperature for 30 rain. After 
24-48h of incubation at 37°C, cultures were examined 
under an inverted microscope. Typically, small colonies of 
between two and eight cells were visible at this time. 
Having confirmed the viability of the culture, a further 
20 ml of medium containing 20% FBS with the appropriate 
inducer was added to each dish; subsequently 25% of 
the total volume in the dish was replaced every 3--4 days. 
Discrete colonies (1 mm diameter) of putative differ- 
entiation resistant variants appeared three to four weeks 
later. These colonies were picked out with a pasteur pipette 
and placed in a small volume of fresh inducer containing 
medium. The colonies were not disrupted and allowed to 
seed cells from their outer margins into the medium. 
These small cultures were examined regularly, main- 
tained at a density of less than 8 x 105/ml and expanded 
for cryopreservation (routinely this takes about 4-5 weeks 
from the time of removal from soft-agar). 
RESULTS 
Stability of differentiation competence 
In order to determine the specificity of the selection 
technique the effect of soft-agar cloning and long- 
term growth on the differentiation competence of the 
HL-60 parent line was investigated. The subclone 
HL-60-LP was selected from a soft-agar culture of 
the parent line in the absence of a differentiation 
inducing agent. These cells were maintained in cul- 
ture for six months (approximately 50 passages) 
before comparison with the HL-60 parent. The 
parent clone grows with a doubling time of approxi- 
mately 35 h in 10% FBS (Fig. la), whilst as expected 
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FIG. 1. Effect of DMSO and retinoic acid on the growth 
and NBT reducing activity of the differentiation competent 
HL-60 parent line. Growth kinetics (a) and NBT reducing 
activity (b) of cells in the presence of 1.25% DMSO (11), 
1 ~tM retinoic acid (&) or in the absence of inducers (0). 
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FIG. 2. Effect of DMSO and retinoic acid on the growth and 
NBT reducing activity of the late passage differentiation 
competent HL-60-LP sub-line. Growth kinetics (a) and 
NBT reducing activity (b) of cells in the presence of 1.25% 
DMSO (m), 1 ~tM retinoic acid (A) or in the absence of 
inducers (O). 
the late passage HL-60-LP has a shorter population 
doubling time of approximately 22h (Fig. 2a). How- 
ever, in spite of this the induced ifferentiation kin- 
etics in the parent HL-60 line closely resemble those 
of the HL-60-LP subclone (Figs 1 and 2). In response 
to treatment with 1.25% DMSO they both cease 
proliferation after approximately 72 h (Figs la and 
2a), and more than 80% of the cells in both popu- 
lations display NBT reducing activity by 100 h (Figs 
lb and 2b). When treated with 1 ~tM retinoic acid 
growth arrest becomes apparent after 48 h and the 
fraction of cells with NBT reducing activity exceeds 
80% by 100 h. These observations demonstrate hat 
neither the soft-agar selection, nor the long-term 
growth of cells in culture (fifty passages), in them- 
selves result in the loss of differentiation competence 
in the HL-60 cells. 
Characterisation fHL-R5 
The variant HL-R5 was selected on the basis of its 
clonal growth in soft-agar in the continuous presence 
of 1 ~tM retinoic acid. After expansion, cryo- 
preservation and recovery HL-R5 was cultured for 
24 passages in the absence of retinoic acid, before 
examining its response to treatment with DMSO or 
retinoic acid (Fig. 3). HL-R5 characteristics which 
remain similar to that of the parent line include the 
growth arrest (Fig. 3a) and the increase in NBT 
(Fig. 3b) reducing activity when exposed to DMSO 
(compare Figs 1 and 3) and its doubling time in 
the control inducer free medium. By contrast, 1txM 
retinoic acid fails to induce a reduction in rate of 
proliferation of HL-R5 cells for approximately 100 h 
and the NBT activity increases at a slower rate than 
the wild-type HL-60 cells. This resistance to the 
induction of differentiation by 1 ~M retinoic acid is 
complete in 0.1 ~tM retinoic acid (Fig. 4). At this 
concentration the parent HL-60 cells growth arrest 
by 72 h (Fig. 4a) and by 140 h the fraction of cells 
with NBT reducing activity exceeds 80% (Fig. 4b). 
In HL-R5 cultures even after one month of exposure 
to 0.1 ~tM retinoic acid there is no sign of growth 
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FIG. 3. Effect of DMSO and retinoic acid on the growth 
and NBT reducing activity of the variant HL-R5. Growth 
kinetics (a) and NBT reducing activity (b) of cells in the 
presence of 1.25% DMSO (U), 1 gM retinoic acid (&) or 
in the absence of inducers (O). 
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FIG. 4. Comparison of the effect of retinoic acid on the 
growth and NBT activity of the differentiation competent 
HL-60 parent line and the variant HL-R5. Growth kinetics 
(a) and NBT reducing activity (b) of HL-60 parent cells in 
the presence of 0.1 ~tM retinoic acid ([:3), or in the absence 
of the inducer (m). HL-R5 cells in the presence of 0.1 IxM 
retinoic acid (Q), or in the absence of the inducer (0). 
of NBT reducing cells remains at the background 
level of 5-15%. 
Characterisation of  HL -D4 
The HL-D4 variant was selected on the basis of its 
clonal growth in soft-agar in the continuous presence 
of 1.25% DMSO in conditions which were otherwise 
the same as that described for HL-R5. In the absence 
of inducing agents this variant grows at a similar rate 
(compare Fig. 5a with la) to that of the parent line 
and with a background NBT reducing activity of 4- 
8% (Fig. 5b). The addition of 1.25% DMSO to 
HL-D4 results in a small transient increase in the 
percentage of NBT reducing cells (rising to a peak 
of about 25% at about 100 h) which subsequently 
decline to 8-10%. In 1.25% DMSO HL-D4 cells 
do not become post-mitotic. These cells have been 
grown continuously for periods in excess of two 
months in 1.25% DMSO (doubling time 34 h in the 
untreated cultures compared to 48-53 h in the DMSO 
treated cultures). Interestingly, at higher DMSO con- 
centrations there is evidence of increasing induction 
of differentiation i the HL-D4 cells. Whilst there is 
a linear increase in the fraction of NBT reducing 
cells in the HL-60 cultures, in HL-D4 there is little 
evidence of induction of differentiation at con- 
centrations lower than 1.25% DMSO (Fig. 6). How- 
ever, at 1.55% DMSO the fraction of NBT reducing 
cells in HL-D4 is comparable to that of HL-60 cul- 
tures in 1.15% DMSO. Therefore, the resistance of 
HL-D4 to the induction of NBT reducing activity by 
DMSO is not a consequence of an aberration in the 
NBT reducing metabolism in these cells, but the 
inability of DMSO to induce differentiation at con- 
centrations which does result in differentiation of the 
HL-60 parent clone. This is further demonstrated by 
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FIG. 5. Effect of DMSO and retinoic acid on the growth 
and NBT activity of the variant HL-D4. Growth kinetics 
(a) and NBT reducing activity (b) of cells in the presence 
of 1.25% DMSO (m), 1 ~tM retinoic acid (A) or in the 
absence of inducers (0). 
FIG. 7. Morphological appearance of differentiation competent and the resistant variants HL-R5 and HL- 
D4. HL-60 parent cells uninduced (a), or treated for 190 h with either 1.25% DMSO (b) or 1 ktM retinoic 
acid (c). HL-D4 cells uninduced (d), or treated for 190 h with either 1.25% DMSO (e) or 1 btM retinoic 
acid (f). HL-60-LP cells uninduced (g) or treated for 190 h with either 1.25% DMSO (h) or i gM retinoic 
acid (i). HL-R5 cells uninduced (j), or treated for 190 h with either 1.25% DMSO (k) or 1 ~tM retinoic acid 
(1). Original magnification × 160. 
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FIG. 8. Morphological comparison of HL-60 parent cells 
and HL-R5 treated with 0.1 ~tM retinoic acid. HL-60 (a) 
and HL-R5 cells (c) in the absence of the inducer, or 
treated with 0.1 IxM retinoic acid for 190 h; HL-60 (b), HL- 
R5 (d). 
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FIG. 6. The dose response of HL-D4 to DMSO alone, 
or in combination with retinoic acid as assayed by NBT 
reducing activity. HL-D4 ceils were treated for three days 
with the indicated concentrations of DMSO either alone 
(0) or together with 1 ~tM retinoic acid ((S)). For com- 
parison HL-60 cells were cultured with the indicated con- 
centrations of DMSO alone (I). 
the effect of increasing concentrations of DMSO 
when HL-D4 is cultured in the presence of a constant 
1 ~tM retinoic acid concentration. Under these con- 
ditions the fraction of NBT positive cells in HL-D4 
cultures is comparable to that induced in HL-60 
by similar DMSO concentrations in the absence of 
retinoic acid (Fig. 6). Therefore, the combination 
treatment of HL-D4 with 1.25% DMSO and 1 ~tM 
retinoic acid, results in the induction of dif- 
ferentiation with near normal kinetics (growth and 
morphology data not shown). However, retinoic acid 
alone does not induce differentiation i HL-D4. In 
response to 1 ~tM retinoic acid even after 200 h of 
culture only 35% of the cells (in some experiments 
about 50%) show NBT reducing activity (Fig. 5b). 
The continuation of these cultures for a further 160 h 
failed to significantly increase the fraction of NBT 
positive cells. We have also continuously grown HL- 
D4 for periods in excess of one month in the presence 
of 0.1 ~xM retinoic acid without any sign of ter- 
mination of growth or induction of differentiation. 
These properties are in marked contrast o the rapid 
induction of differentiation by retinoic acid in the 
wild-type HL-60 parent clone (see Fig. 2). 
Effect of DMSO and retinoic acid on cell morphology 
In the absence of inducers of differentiation both 
HL-60 parent and the HL-60-LP clone (Figs 7a and 
g respectively) show the characteristic histological 
features, including large round regular nuclei and 
grainy cytoplasms. After 190h in the presence of 
1.25% DMSO (Figs 7b and h), or 1 ~tM retinoic acid 
(Figs 7c and i) both appear to have irregular shaped 
cells, smaller lobular nuclei and less grainy cyto- 
plasm. Comparison of HL-D4 with either of the 
differentiation competent clones in the absence of 
the inducers hows HL-D4 to have a slightly smaller 
nucleus and less grainy cytoplasm (compare Fig. 7d 
with 7a and 7g). After treatment with 1.25% DMSO 
HL-D4 still retains the regular nuclear shape (Fig. 
7e) and differs markedly from the treated HL-60 
parent (Fig. 7b). Similarly, after treatment with 1 ~M 
retinoic acid (Fig. 7f) these cells resemble much more 
closely the untreated cultures (Figs 7a, d, g and j) 
than they do the treated differentiation competent 
clones (Figs 7c and i). 
In the absence of DMSO or retinoic acid HL-R5 
cells (Fig. 7j ) look indistinguishable from the HL-60 
parent (Fig. 7a), and treatment with 1.25% DMSO 
clearly results in the appearance ofwell differentiated 
cells (Fig. 7k). However, when HL-R5 cells are cul- 
tured in the presence of 1 ~tM retinoic acid (Fig. 71) 
there is a much reduced evidence of differentiation; 
a large percentage of the cells retain large and rela- 
tively regular nuclei. 
When the HL-60 parent and the HL-R5 variant 
are treated with 0.1 ~tM retinoic acid there is a much 
more pronounced emonstration f the resistance of 
HL-R5 to the induction of differentiation by retinoic 
acid (Fig. 8). The HL-60 parent clone appears well 
differentiated after 190 h of exposure to 0.1 ~tM reti- 
noic acid (Fig. 8b). By contrast HL-R5 cells similarly 
treated (Fig. 8d) appear indistinguishable from those 
untreated (Fig. 8c) or the control HL-60 cells (Fig. 
8a). Therefore, the morphological appearance of 
these cells are concurrent with the growth and NBT 
reducing activity data presented above. 
DISCUSSION 
The availability of a suitable panel of resistant 
variants in which a single genetic lesion blocks the 
onset of differentiation i otherwise proficient HL- 
60 cells would be a powerful tool for the analysis of 
the molecular mechanisms involved in the dif- 
ferentiation of these cells. A number of laboratories 
have reported the isolation of spontaneously arising 
HL-60 variants. These appear to represent, earlier, 
less mature myeloid cells [16, 17], and the origin of 
at least one such line is now in doubt [17, 18]. In 
addition several differentiation resistant HL-60 vari- 
ants have been isolated following either mutagenesis 
[19-22], or continuous culture for extended periods 
in the presence of increasing concentrations of an 
inducing agent [23-25]. Both procedures increase the 
risk of multiple genetic lesions, due to high mutation 
rates and amplifications of large DNA segments 
which could span several genes [22]. In addition, 
the variants should ideally be selected from early 
passage, fully differentiation competent cultures in 
order to reduce the risk of accumulation of multiple 
414 DAVID C, DARLING et al. 
lesions as is likely to be the case in very late passage 
cultures [36, 37]. The cloning procedure described 
here enables the single-step isolation of a large num- 
ber of clonal populations of differentiation resistant 
variants which arise spontaneously in cultures 
exposed to a single optimum dose of an inducing 
agent. This simple procedure, which obviates the 
need for mutagenesis or continuous culture in 
increasing concentrations of the inducing agents, 
optimises the chance of obtaining variants with a 
single lesion and no DNA amplifications. 
Using the conditions described here clonal popu- 
lations of cells resistant to the induction of dif- 
ferentiation by either DMSO or retinoic acid appear 
with a frequency of approximately 10 -5. This high 
frequency is probably due to the presence of the 
documented aneuploidy in the HL-60 cells [2], poss- 
ible functional haploidism, and the involvement of 
multiple steps in the induction of differentiation by 
each of the two agents tested. The karyotype of our 
parent HL-60 clone, which is very similar to the 
karyotype published by Nowell et al. [38], confirms 
the aneuploidy of our parent HL-60 cells. They have 
monosomy 5, 9, 16 and 17 with a single copy of 
the X-chromosome. In addition there may be small 
deletions in the long arm of chromosome 5 and the 
short arm of chromosome 9. They have trisomy 10 
and 18, plus three "marker" chromosomes, as well 
as an average of approximately 20 "double-minute" 
chromosomes. There is no detectable karyotypic dif- 
ference between HL-60 and HL-D4 (HL-R5 not 
karyotyped) (unpublished ata). 
Because DMSO and retinoic acid are chemically 
different agents, they would be expected to act, 
initially, on different pathways. However, since 
exposure to either agent does result in the ultimate 
appearance of the same properties characteristic of
mature myeloid cells, the two initial pathways prob- 
ably converge and share common steps leading to 
the induction of differentiation. Analysis of HL-R5, 
demonstrating resistance to retinoic acid and sen- 
sitivity to DMSO induction of differentiation, sug- 
gests the lesion in these cells to be early in the 
induction pathway. That is up-stream of the point of 
convergence of the two pathways which may be used 
by these agents. By contrast HL-D4 (selected for 
DMSO resistance alone) shows not only resistance to 
DMSO but also retinoic acid induced differentiation. 
The lesion in HL-D4 would therefore appear to be 
beyond the point of convergence of the two 
pathways. This is of course based on the assumption 
that the differentiation resistance of HL-D4 is the 
product of a single lesion. Interestingly, 12-O-tetra- 
decanoylphorbol-13-acetate (TPA) which does 
induce monocytic differentiation i HL-60 and HL- 
R5, does not induce differentiation and appears toxic 
to HL-D4 (data not shown). The nature of the dif- 
ferentiation lesion in these cells, their topological 
relationship to each other and their dominant or 
recessive character can be tested by somatic cell 
hybridisation mediated complementation analysis. 
These studies are currently in progress. 
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